The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

USE OF MEPHENOXALONE IN BEHAVIORAL PROBLEMS

Published Online:https://doi.org/10.1176/ajp.118.9.841

Mephenoxalone appears to be a useful medication for cases demonstrating 14 and 6 per second spikings. Its activity warrants further investigation in the areas of brain damage, especially in the so-called diffuse brain damaged child. Mephenoxalone was used in 31 children with various diagnoses. It proved helpful in 2 types of therapy: drug-symptom focused and psychotherapy-drug adjunctive. Improvement of excellent and good ratings was achieved in 55% of the former and 75% of the latter groups.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.